Purchase Order VA24617P0453
Award Date 10/21/16
Potential Completion Date 10/26/16
Potential Value $75K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Pittsburgh, PA 15275, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $76,548.40 firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Walgreen Co., doing business as Walgreens, for the delivery of LEMTRADA injections. The contract has no set-aside designation and was awarded on July 1, 2018, with a completion date of July 2, 2018. Walgreens is a major federal contractor and grant recipient, leveraging its nationwide network of retail pharmacies to support various federal healthcare initiatives, including COVID-19...
- This is a federal purchase order contract awarded by the Veterans Integrated Service Network 5 (VISN 5), a civilian agency, to Walgreen Co. (Walgreens) for LEMTRADA IV injections. The contract has a ceiling value of $76,548.40 and a firm fixed price pricing type, with an ultimate completion date of April 2, 2018. The contract was not set aside for any specific business type. Walgreens, a major pharmacy health and daily living retailer, has been awarded several federal contracts and grants to...
- This firm fixed-price purchase order contract was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The $75,208.70 contract is for the provision of pharmaceutical products, with a focus on specialized medications for rare, chronic, or complex medical conditions, such as Jynarque (tolvaptan) for autosomal dominant polycystic kidney disease. The contract does not have a...
- This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Walgreens Specialty Pharmacy, LLC, a for-profit organization, to provide the specialty pharmaceutical product JYNARQUE to the Puget Sound VA Health Care System (VAHCS). The contract has a potential value of $312,685.57 and a period of performance through September 30, 2023. No set-aside designation was used for this award. Walgreens Specialty Pharmacy,...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 2 (VISN 2) to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The contract, valued at $13,242.99, is for the emergency procurement of the medication Jynarque (tolvaptan) to support the VA's healthcare services for veterans. The contract has a period of performance through July 7, 2025 and does not have a set-aside designation,...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The contract, valued at $83,000.32, is for the supply of the pharmaceutical drug JYNARQUE (tolvaptan) to treat autosomal dominant polycystic kidney disease. The contract does not have a set-aside designation and has an ultimate completion date of September 30, 2021. Walgreens...
- The U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm fixed price purchase order to Walgreens Specialty Pharmacy, LLC in the amount of $12,580.72. The contract is for the delivery of the medication Jynarque (tolvaptan) to treat autosomal dominant polycystic kidney disease. This contract was awarded to Walgreens Specialty Pharmacy as the prime contractor, with no set-aside designation mentioned. The contract period of performance runs through March 19,...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded Walgreens Specialty Pharmacy, LLC a firm fixed price purchase order valued at approximately $48,000 to deliver pharmaceutical Jynarque from October 31, 2022 through November 30, 2022. As the prime contractor, Walgreens Specialty Pharmacy, LLC will perform under the contract from its place of performance in San Francisco, California to support the VA-VHA's healthcare programs for...
- Walgreens Specialty Pharmacy, LLC was awarded a firm fixed price purchase order as the prime contractor for $12,580.72 to deliver Jynarque 45MG/15MG tablets to the Department of Veterans Affairs Veterans Health Administration (VHA) Veterans Integrated Service Network 2 in Pittsburgh, Pennsylvania. The purchase order was awarded on February 9, 2024 and requires completion by May 9, 2024. No set aside designation was applied. As the prime contractor, Walgreens Specialty Pharmacy will fulfill...
- The Department of Veterans Affairs Veterans Health Administration awarded Walgreens Specialty Pharmacy, LLC a firm fixed-price purchase order valued at twelve thousand two hundred twenty four dollars and sixty cents ($12,224.60) to deliver JYNARQUE 45MG/15MG tablets. Performance will occur in Pittsburgh, Pennsylvania over a period of three months from December 2023 through March 2024. The Veterans Integrated Service Network 2 is the funding agency within the VA-VHA supporting healthcare services...